Prashant Bommi

Prashant Bommi, PhD, is a Research Assistant Professor at the Stritch School of Medicine, Loyola University Chicago, where he is affiliated with the Wainwright Laboratory and the Cancer Center. His work bridges molecular oncology, immunology, and targeted therapeutics, with a focus on glioblastoma and age-related immune dysfunction.

His research interests include:

• Glioblastoma biology and therapy
• PROTAC (proteolysis-targeting chimera)-mediated immune modulation
• Geriatric immune response in cancer

Dr. Bommi’s work contributes to the development of novel immunomodulatory strategies for brain tumors, particularly through targeted protein degradation technologies. His research is aligned with translational oncology and molecular therapeutics.

He is actively engaged in the research community at Loyola University Chicago and contributes to the mission of the Cancer Biology and Cell Cycle (CBCC) research program.

Dr. Bommi has not listed any scientific awards or honors in the provided text.

He mentors within the research environment of the Wainwright Laboratory and is involved in collaborative cancer research, though specific advisees are not named. There is no mention of external grants, but his position suggests involvement in funded research projects.

He is part of the research team at the Wainwright Laboratory, which is integrated within the Cancer Center at Loyola University Chicago, focusing on innovative approaches to cancer treatment and immune system modulation.